🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: ActHIB®

Found 44 matching trials

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine

PHASE1

The purpose of this study is to show that ViscoGel® is safe when administra...

Status

Completed

Location

Karolinska Trial Alliance

Start Date

2012-03

Trial ID

NCT01578070

Treatments Being Tested

0.2μg Act-HIB®ViscoGel® and 0.2μg Act-HIB®ViscoGel® and 2μg Act-HIB®2μg Act-HIB®10μg Act-HIB®

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

PHASE2

This study is evaluating the safety and immunogenicity of GSK Biologicals' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2004-08-01

Trial ID

NCT00129129

Treatments Being Tested

GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine ActHIB Pediarix Prevnar Menomune

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

PHASE3

The purpose of this trial is to clinically confirm that the manufacturing p...

Status

Completed

Location

Multiple Locations

Start Date

2006-11

Trial ID

NCT00404651

Treatments Being Tested

DTaP-IPV-HB-PRP~T vaccine DTaP-IPV-HB-PRP~T vaccine DTaP-IPV-HB-PRP~T vaccine DTaP-HBV-IPV vaccine

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

PHASE3

The purpose of this study is to document the immunological response to the ...

Status

Completed

Location

Multiple Locations

Start Date

2006-08

Trial ID

NCT00362336

Treatments Being Tested

DTaP-IPV-HB-PRP~T CombAct-HIB®Engerix B® Pediatric

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

PHASE3

To demonstrate that the immune response to hepatitis B antigen of the DTaP-...

Status

Completed

Location

Multiple Locations

Start Date

2006-07

Trial ID

NCT00315055

Treatments Being Tested

DTaP-IPV-HB-PRP~T vaccine DTaP-IPV//PRP~T combined Hepatitis B vaccine

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

PHASE3

This study is designed to evaluate in a controlled manner the effect of Pre...

Status

Completed

Location

Multiple Locations

Start Date

2003-10

Trial ID

NCT00772928

Treatments Being Tested

Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

PHASE3

This study is a Phase 3, randomized, modified double-blind study which aims...

Status

Active Not Recruiting

Location

Investigational Site Number : 0560004

Start Date

2025-05-22

Trial ID

NCT06975878

Treatments Being Tested

PCV21 vaccine Vaxneuvance vaccine Hexyon vaccine M-M-RvaxPro vaccine Varivax vaccine

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

PHASE2

The study investigated safety profile and the antibody responses to an expe...

Status

Completed

Location

Multiple Locations

Start Date

2003-08

Trial ID

NCT00771849

Treatments Being Tested

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Haemophilus Influenzae Type b (Hib) vaccine

Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants

PHASE3

The purpose of the study is to provide immunogenicity and safety data of th...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00401531

Treatments Being Tested

DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines DTaP-HB-IPV and Pneumococcal polysaccharide vaccines

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

PHASE2

This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-04-11

Trial ID

NCT00134719

Treatments Being Tested

MenHibrix (Hib-MenCY-TT)Infanrix® Penta Prevenar®ActHIB®Meningitec®M-M-R®II Varivax®PedvaxHIB®

Previous Next